These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35793762)

  • 1. Left ventricular function is related with amphiregulin and fibrosis markers in cirrhotic cardiomyopathy.
    Grzebyk E; Pazgan-Simon M; Jagas J; Zuwala-Jagiello J; Gorka-Dynysiewicz J
    J Physiol Pharmacol; 2022 Feb; 73(1):. PubMed ID: 35793762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum versus Imaging Biomarkers in Friedreich Ataxia to Indicate Left Ventricular Remodeling and Outcomes.
    Mehta N; Chacko P; Jin J; Tran T; Prior TW; He X; Agarwal G; Raman SV
    Tex Heart Inst J; 2016 Aug; 43(4):305-10. PubMed ID: 27547137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of cardiomyocyte injury and stress identify left atrial and left ventricular remodelling and dysfunction: A population-based study.
    Ravassa S; Kuznetsova T; Varo N; Thijs L; Delles C; Dominiczak A; Díez J; Staessen JA
    Int J Cardiol; 2015 Apr; 185():177-85. PubMed ID: 25796005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis.
    Lebedev DA; Lyasnikova EA; Vasilyeva EY; Babenko AY; Shlyakhto EV
    J Diabetes Res; 2020; 2020():6976153. PubMed ID: 33224989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy.
    Aguiar P; Azevedo O; Pinto R; Marino J; Cardoso C; Sousa N; Cunha D; Hughes D; Ducla Soares JL
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29535138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix turnover biomarkers predict long-term left ventricular remodeling after myocardial infarction: insights from the REVE-2 study.
    Eschalier R; Fertin M; Fay R; Bauters C; Zannad F; Pinet F; Rossignol P
    Circ Heart Fail; 2013 Nov; 6(6):1199-205. PubMed ID: 23983248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the PPARGC1A Gly482Ser polymorphism on left ventricular structural and functional abnormalities in patients with hypertension.
    Rojek A; Cielecka-Prynda M; Przewlocka-Kosmala M; Laczmanski L; Mysiak A; Kosmala W
    J Hum Hypertens; 2014 Sep; 28(9):557-63. PubMed ID: 24718382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of N-terminal propeptide of the brain natriuretic peptide in predicting left ventricular diastolic dysfunction diagnosed by tissue Doppler imaging in patients with chronic liver disease.
    Raedle-Hurst TM; Welsch C; Forestier N; Kronenberger B; Hess G; Herrmann E; Zeuzem S; Raedle J
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):865-73. PubMed ID: 18794600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Anti-Beta-1-Adrenergic Receptor Antibodies in Cardiac Dysfunction in Patients with Cirrhotic Cardiomyopathy.
    Ma L; Liu X; Wu Q; Hu X; Liu H; Zhang J; Lee SS
    J Cardiovasc Transl Res; 2022 Apr; 15(2):381-390. PubMed ID: 34417673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum N-terminal pro-B-type natriuretic peptide and left ventricle diastolic dysfunction in patients with hepatitis C virus infection.
    Che W; Liu W; Wei Y; Xu Y; Hou L; Matsumori A; Hu D
    J Viral Hepat; 2012 May; 19(5):327-31. PubMed ID: 22497811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure.
    Rusconi PG; Ludwig DA; Ratnasamy C; Mas R; Harmon WG; Colan SD; Lipshultz SE
    Am Heart J; 2010 Oct; 160(4):776-83. PubMed ID: 20934575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.
    Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; O'Moore-Sullivan T; Marwick TH
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1239-49. PubMed ID: 22172779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Extracellular Matrix Remodeling during Left Ventricular Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
    Krebber MM; van Dijk CGM; Vernooij RWM; Brandt MM; Emter CA; Rau CD; Fledderus JO; Duncker DJ; Verhaar MC; Cheng C; Joles JA
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of carboxyterminal propeptide of type I procollagen and left ventricular remodeling after myocardial infarction.
    Takino T; Nakamura M; Hiramori K
    Cardiology; 1999; 91(2):81-6. PubMed ID: 10449877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitive cardiac troponin T: a biomarker of left-ventricular diastolic dysfunction in hemodialysis patients.
    Sun L; Ji Y; Wang Y; Ding M; Xie X; Zhu D; Chen F; Zhang N; Wang X
    J Nephrol; 2018 Dec; 31(6):967-973. PubMed ID: 30350298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRR.
    Rubiś P; Wiśniowska-Śmiałek S; Biernacka-Fijałkowska B; Rudnicka-Sosin L; Wypasek E; Kozanecki A; Dziewięcka E; Faltyn P; Karabinowska A; Khachatryan L; Hlawaty M; Leśniak-Sobelga A; Kostkiewicz M; Płazak W; Podolec P
    Heart Vessels; 2017 Jun; 32(6):714-725. PubMed ID: 28004175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade.
    Kosmala W; Przewlocka-Kosmala M; Szczepanik-Osadnik H; Mysiak A; Marwick TH
    Heart; 2013 Mar; 99(5):320-6. PubMed ID: 23343682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dynamics of Parameters of Transmitral Blood Flow and Markers of Myocardial Fibrosis in Patients with Myocardial Infarction].
    Osokina AV; Karetnikova VN; Polikutina OM; Ivanova AV; Artemova TP; Ryzhenkova SN; Avramenko OE; Gruzdeva OV; Barbarash OL
    Kardiologiia; 2020 Jul; 60(6):994. PubMed ID: 32720621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.